Consolidated cash flow statements
(thousands of €) |
2019 |
2018 |
Notes |
---|---|---|---|
Net profit/loss (-) of the year |
149,845 |
(29,259) |
|
|
|
|
|
Adjustment for non-cash transactions |
248,027 |
21,753 |
|
Adjustment for items to disclose separately under operating cash flow |
(7,731) |
(4,389) |
|
Adjustment for items to disclose under investing and financing cash flows |
(5,061) |
(668) |
|
Change in working capital other than deferred income |
12,698 |
19,922 |
|
Increase/decrease (-) in deferred income |
2,804,202 |
(153,312) |
|
|
|
|
|
Cash generated/used (-) in operations |
3,201,980 |
(145,953) |
|
|
|
|
|
Interest paid |
(1,158) |
(1,063) |
|
Interest received |
7,852 |
4,558 |
|
Corporate taxes paid |
(57) |
(8) |
|
|
|
|
|
Net cash flows generated/used (-) in operating activities |
3,208,617 |
(142,466) |
|
|
|
|
|
Purchase of property, plant and equipment |
(22,385) |
(10,392) |
|
Purchase of and expenditure in intangible fixed assets |
(23,300) |
(3,325) |
|
Proceeds from disposal of property, plant and equipment |
– |
1 |
|
Increase in current financial investments |
(4,787,284) |
– |
|
Interest received related to current financial investments |
5,059 |
– |
|
Decrease in current financial investments |
1,063,344 |
– |
|
Acquisition of financial assets held at fair value through profit or loss |
(177) |
(4,559) |
|
Proceeds from sale of financial assets held at fair value through profit or loss |
82 |
2,361 |
|
|
|
|
|
Net cash flows used in investing activities |
(3,764,660) |
(15,914) |
|
|
|
|
|
Payment of lease liabilities |
(5,091) |
(5) |
|
Proceeds from capital and share premium increases, gross amount |
960,087 |
296,188 |
|
Issue costs paid related to capital and share premium increases |
(4,447) |
(15,964) |
|
Proceeds from capital and share premium increases from exercise of warrants |
17,167 |
7,657 |
|
Proceeds from capital and share premium increases from exercise of warrant A by Gilead |
368,035 |
– |
|
|
|
|
|
Net cash flows generated in financing activities |
1,335,751 |
287,876 |
|
|
|
|
|
Increase in cash and cash equivalents |
779,708 |
129,497 |
|
Cash and cash equivalents at beginning of year |
1,290,796 |
1,151,211 |
|
|
|
|
|
Transfer to current financial investments |
(198,922) |
– |
|
|
|
|
|
Increase in cash and cash equivalents |
779,708 |
129,497 |
|
|
|
|
|
Effect of exchange rate differences on cash and cash equivalents |
(9,966) |
10,089 |
|
|
|
|
|
Cash and cash equivalents at end of the year |
1,861,616 |
1,290,796 |
The accompanying notes form an integral part of these financial statements.